SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,306 JPY | +2.21% |
|
+2.70% | +7.47% |
| Apr. 25 | Shionogi & Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Apr. 19 | Shionogi & Co Completes Cancellation of 10.84 Million Treasury Shares | MT |
| Sales 2024 * | 445B 2.81B | Sales 2025 * | 419B 2.64B | Capitalization | 2,071B 13.08B |
|---|---|---|---|---|---|
| Net income 2024 * | 160B 1.01B | Net income 2025 * | 146B 920M | EV / Sales 2024 * | 3.59 x |
| Net cash position 2024 * | 473B 2.99B | Net cash position 2025 * | 566B 3.57B | EV / Sales 2025 * | 3.6 x |
| P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
14.4
x | Employees | 5,680 |
| Yield 2024 * |
2.06% | Yield 2025 * |
2.13% | Free-Float | 88.4% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +2.21% | ||
| 1 week | +2.70% | ||
| Current month | -5.73% | ||
| 1 month | -5.79% | ||
| 3 months | +2.86% | ||
| 6 months | +6.86% | ||
| Current year | +7.47% |
1 week
7 128.00
7 393.00
1 month
7 062.007 824.00
Current year
6 741.008 137.00
1 year
5 718.008 137.00
3 years
5 438.008 439.00
5 years
4 379.008 439.00
10 years
1 738.008 439.00
| Managers | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Yuji Hosogai
DFI | Director of Finance/CFO | - | - |
Yasuetsu Imune
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 74 | 19-05-31 |
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Takuko Sawada
BRD | Director/Board Member | 69 | 77-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 15 M€ | +7.34% | ||
| 2.51% | 5 M€ | +6.34% | - | |
| 1.07% | 60 M€ | +14.42% | ||
| 1.05% | 11 M€ | +10.37% | - | |
| 1.04% | 251 M€ | +13.17% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 7,306 | +2.21% | 778,400 |
| 24-04-25 | 7,148 | -2.66% | 647,900 |
| 24-04-24 | 7,343 | 0.00% | 653,400 |
| 24-04-23 | 7,343 | +1.05% | 579,900 |
| 24-04-22 | 7,267 | +2.15% | 626,400 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am EDT
More quotes
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,306
JPY
Average target price
7,721
JPY
Spread / Average Target
+5.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.47% | 13.03B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
- Stock Market
- Equities
- 4507 Stock
